BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Decker JM, Filho OV, Freitas MO, Silva-Fernandes IJ, Dantas TS, Campêlo CS, Cunha MD, Silva PG, Sousa FB. PMS2: a potential prognostic protein marker in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2021;26:e451-8. [PMID: 33247565 DOI: 10.4317/medoral.24303] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang D, Song Q, Wei X, Yu Z, Liu Y, Wang H, Wang X, Huang J, Su J, Hong Y, Xu Y, Xu C, Hou Y. PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma. Front Oncol 2022;12:897527. [DOI: 10.3389/fonc.2022.897527] [Reference Citation Analysis]
2 Yang J, Pan Y, Peng L, Zhang L, Zhao J, Zheng Z, Zheng J, Xu X, Zeng Y, Guo X. Upregulation of Synuclein-γ and Snai1 Contributes to Poor Clinical Prognosis in Oral Squamous Cell Carcinoma Patients. BioMed Research International 2022;2022:1-13. [DOI: 10.1155/2022/6534626] [Reference Citation Analysis]